Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Availability Heuristic01:08

The Availability Heuristic

7.2K
A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[In Memoriam: Dr. Francisco José Sánchez-Muniz].

Nutricion hospitalaria·2026
Same author

[Health-related quality of life in outpatients with cancer and disease-related malnutrition undergoing medical nutritional therapy: Assessment using the AnyVida scale].

Nutricion hospitalaria·2026
Same author

Research and scientific publication in Pediatrics in Spain.

Anales de pediatria·2026
Same author

[Editor's corner. 2025 balance sheet].

Nutricion hospitalaria·2026
Same author

Sex-specific CT-derived muscle and fat phenotypes in colon cancer: implications for nutritional and metabolic assessment.

Frontiers in nutrition·2025
Same author

[XVI Jesús Culebras Lecture. Development of eating habits in children: sense and sensitivity].

Nutricion hospitalaria·2025

Related Experiment Video

Updated: Mar 15, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

48.7K

[Not Available].

Rosa Burgos Peláez1, María Cristina Cuerda Compes, Pedro P García-Luna

  • 1Unidad de Soporte Nutricional. Hospital Universitario Vall d'Hebron. Barcelona. rburgos@vhebron.net.

Nutricion Hospitalaria
|August 31, 2016
PubMed
Summary

Teduglutide significantly reduces parenteral nutrition (PN) dependence in short bowel syndrome (SBS) patients. This therapy improves intestinal absorption, decreasing the need for PN and achieving independence in some individuals.

Keywords:
Fallo intestinal. Teduglutida. Síndrome de intestino corto. GLP-2. Nutrición parenteral.

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

25.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

22.8K

Related Experiment Videos

Last Updated: Mar 15, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

48.7K
Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

25.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

22.8K

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Clinical Medicine

Background:

  • Long-term parenteral nutrition (PN) is associated with severe complications and reduced quality of life in patients with short bowel syndrome (SBS).
  • Teduglutide, a glucagon-like peptide-2 analog, represents a novel, non-symptomatic therapeutic approach for SBS.
  • Existing treatments primarily focus on symptom management, highlighting the need for therapies that address the underlying malabsorption.

Purpose of the Study:

  • To review preclinical and clinical data on the efficacy and safety of teduglutide for treating short bowel syndrome.
  • To evaluate teduglutide's impact on reducing parenteral nutrition dependence in SBS patients.
  • To assess teduglutide's potential to improve intestinal absorption and patient outcomes.

Main Methods:

  • A Phase III, 24-week, double-blind, placebo-controlled study (STEPS) was the basis for teduglutide's approval.
  • Patients with SBS-associated intestinal failure requiring PN ≥ 3 times/week for ≥ 12 months received either teduglutide (0.05 mg/kg/day) or placebo subcutaneously.
  • Efficacy was measured by the proportion of responders, reduction in PN volume, and decrease in PN days per week.

Main Results:

  • Significantly more patients in the teduglutide group responded compared to placebo (63% vs. 30%; p = 0.002) at 24 weeks.
  • Teduglutide demonstrated a significantly greater mean absolute reduction in PN volume from baseline (4.4 L/week vs. 2.3 L/week; p < 0.001).
  • PN requirements decreased by at least one day per week in 54% of teduglutide recipients versus 23% of placebo recipients; 12% achieved complete PN independence.

Conclusions:

  • Teduglutide effectively enhances intestinal absorption in patients with short bowel syndrome.
  • The drug significantly reduces and can eliminate the need for parenteral nutrition, improving patient outcomes.
  • Teduglutide is generally well-tolerated, offering a promising therapeutic option for SBS management.